Literature DB >> 10340383

DNA-PK, the DNA-activated protein kinase, is differentially expressed in normal and malignant human tissues.

U Moll1, R Lau, M A Sypes, M M Gupta, C W Anderson.   

Abstract

DNA-PK is a nuclear, serine/threonine protein kinase required for repairing DNA double-strand breaks and for V(D)J recombination. To determine the distribution of DNA-PK in human tissues, we assayed paraffin-embedded sections of normal and cancerous tissues for DNA-PKcs and Ku80 by immunohistochemistry. We also assayed for Brca2, a human tumor suppressor gene that is implicated in the repair of DNA strand-breaks. Brca2 was strongly expressed in epithelial cells of the breast, endometrium, and thymus, in tingible body macrophages of follicular germinal centers of lymphoid tissue, and in reticuloendothelial cells in the spleen. DNA-PKcs and Ku80 expression was usually parallel, but both were expressed in a highly cell- and tissue-specific manner. The highest levels were observed in spermatogenic cells (but not in spermatozoa), and in neurons and glial cells of the central and autonomic nervous system. Neither protein was consistently expressed in liver nor in resting mammary epithelium, but lactating breast epithelium was strongly positive for DNA-PKcs and Ku80. In contrast to established human cell cultures, expression between cells in the same tissue was highly selective in the epidermis, exocrine pancreas, renal glomeruli, the red pulp of the spleen, and within cellular compartments of tonsils, lymph nodes, and thymus. Most cancerous tissues were consistently positive for DNA-PKcs and Ku80, except invasive carcinoma of the breast. DNA-PKcs, Ku80, and Ku70 mRNAs were expressed in all normal tissues with relatively little variation in levels. Our results suggest that the apparent absence of DNA-PKcs and Ku80 from some cells or tissues is a consequence of post-transcriptional mechanisms that regulate protein levels.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10340383     DOI: 10.1038/sj.onc.1202640

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  25 in total

1.  The SET domain protein Metnase mediates foreign DNA integration and links integration to nonhomologous end-joining repair.

Authors:  Suk-Hee Lee; Masahiko Oshige; Stephen T Durant; Kanwaldeep Kaur Rasila; Elizabeth A Williamson; Heather Ramsey; Lori Kwan; Jac A Nickoloff; Robert Hromas
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-06       Impact factor: 11.205

2.  Inhibition of homologous recombination by variants of the catalytic subunit of the DNA-dependent protein kinase (DNA-PKcs).

Authors:  Erin Convery; Euy Kyun Shin; Qi Ding; Wei Wang; Pauline Douglas; Laurie S Davis; Jac A Nickoloff; Susan P Lees-Miller; Katheryn Meek
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-24       Impact factor: 11.205

Review 3.  Basic mechanisms of therapeutic resistance to radiation and chemotherapy in lung cancer.

Authors:  Henning Willers; Christopher G Azzoli; Wil L Santivasi; Fen Xia
Journal:  Cancer J       Date:  2013 May-Jun       Impact factor: 3.360

Review 4.  Mouse models for radiation-induced cancers.

Authors:  Leena Rivina; Michael J Davoren; Robert H Schiestl
Journal:  Mutagenesis       Date:  2016-05-21       Impact factor: 3.000

5.  Molecular cloning and characterization of rKAB1, which interacts with KARP-1, localizes in the nucleus and protects cells against oxidative death.

Authors:  Eunju Do; Eiichi Taira; Yasuyuki Irie; Yehua Gan; Hidekazu Tanaka; Che-Hui Kuo; Naomasa Miki
Journal:  Mol Cell Biochem       Date:  2003-06       Impact factor: 3.396

6.  Variations in ATM protein expression during normal lymphoid differentiation and among B-cell-derived neoplasias.

Authors:  Jane Starczynski; William Simmons; Joanne R Flavell; Phillip J Byrd; Grant S Stewart; Harjit S Kullar; Alix Groom; John Crocker; Paul A H Moss; Gary M Reynolds; Meri Glavina-Durdov; A Malcolm R Taylor; Christopher Fegan; Tatjana Stankovic; Paul G Murray
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

7.  Telomere dysfunction and DNA-PKcs deficiency: characterization and consequence.

Authors:  Eli S Williams; Rebekah Klingler; Brian Ponnaiya; Tanja Hardt; Evelin Schrock; Susan P Lees-Miller; Katheryn Meek; Robert L Ullrich; Susan M Bailey
Journal:  Cancer Res       Date:  2009-02-24       Impact factor: 12.701

8.  Valosin-containing protein regulates the proteasome-mediated degradation of DNA-PKcs in glioma cells.

Authors:  N Jiang; Y Shen; X Fei; K Sheng; P Sun; Y Qiu; J Larner; L Cao; X Kong; J Mi
Journal:  Cell Death Dis       Date:  2013-05-30       Impact factor: 8.469

9.  DNA-PK is a DNA sensor for IRF-3-dependent innate immunity.

Authors:  Brian J Ferguson; Daniel S Mansur; Nicholas E Peters; Hongwei Ren; Geoffrey L Smith
Journal:  Elife       Date:  2012-12-18       Impact factor: 8.140

10.  The role and clinical significance of DNA damage response and repair pathways in primary brain tumors.

Authors:  Wil L Santivasi; Fen Xia
Journal:  Cell Biosci       Date:  2013-02-06       Impact factor: 7.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.